Show
Sort by
-
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2) : a randomised, double-blind, placebo-controlled, phase 3 trial
-
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1) : a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
-
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT) : a randomised, double-blind, placebo-controlled phase 3 trial
-
Performance of 3 enthesitis indices in patients with peripheral spondyloarthritis during treatment with adalimumab
-
- Journal Article
- A1
- open access
Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritis
-
- Journal Article
- A1
- open access
Referral patterns, diagnosis, and disease management of patients with axial spondyloarthritis: results of an international survey
-
Sustained clinical remission in patients with non-radiographic axial spondyloarthritis after two years of adalimumab treatment
-
Better performance of the Leeds and Sparcc enthesitis indices compared to the mases in patients with peripheral spondyloarthritis during treatment with adalimumab